ArticleiScience2026

Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activity.

Sven Kratochvil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.